Incyte (INCY) Common Stock Issued (2009 - 2026)
Incyte (INCY) recorded Common Stock Issued of $122.3 million in Q3 2026, up 181.6% from $43.43 million a year earlier and up 62.7% from the prior quarter.
Powered by 
Analysis
Incyte (INCY) Common Stock Issued (2009 - 2026) Analysis & Trends
On a TTM basis, Incyte's Common Stock Issued came in at $455.59 million as of Sep 30, 2026, up 381.5% year-over-year; for FY2025, it came in at $221.76 million, up 349.8% from FY2024.
- Annual Common Stock Issued has a five-year compound annual growth rate of 10.8% (FY2020 to FY2025).
- Across earlier years, Common Stock Issued came in at $49.3 million in FY2024 (+37.6%), $35.84 million in FY2023 (-41.4%), $61.12 million in FY2022 (+4.2%) and $58.63 million in FY2021 (-55.9%).
- Quarterly Common Stock Issued has ranged from -$48,000 in Q3 2023 to $160.21 million in Q4 2025 over the past five years.
- Peak year-over-year performance for Common Stock Issued in the last five years was growth of 579.0% in Q1 2025, against a decline of 96.6% in Q1 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $75.15 million (Q2 2026), $97.93 million (Q1 2026) and $160.21 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 743.00 Mn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 247.00 Mn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 4.00 Mn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 87.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | Incyte | 245.42 Mn | -15.74 Bn | 1.45 Bn | 122.30 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 122.30 Mn |
| Jun 30, 2026 | 75.15 Mn |
| Mar 31, 2026 | 97.93 Mn |
| Dec 31, 2025 | 160.21 Mn |
| Sep 30, 2025 | 43.43 Mn |
| Jun 30, 2025 | 14.88 Mn |
| Mar 31, 2025 | 3.24 Mn |
| Dec 31, 2024 | 33.06 Mn |
| Sep 30, 2024 | 1.28 Mn |
| Jun 30, 2024 | 14.48 Mn |
| Mar 31, 2024 | 477,000.00 |
| Dec 31, 2023 | 7.52 Mn |
| Sep 30, 2023 | -48,000.00 |
| Jun 30, 2023 | 14.38 Mn |
| Mar 31, 2023 | 13.99 Mn |
| Dec 31, 2022 | 18.13 Mn |
| Sep 30, 2022 | 5.30 Mn |
| Jun 30, 2022 | 21.29 Mn |
| Mar 31, 2022 | 16.40 Mn |
| Dec 31, 2021 | 10.19 Mn |
API Access
Incyte Common Stock Issued API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-stock-issued&ticker=INCY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-stock-issued", "ticker": "INCY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-stock-issued&ticker=INCY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();